Anavex Life Sciences Announces Board Refresh Plans at 2026 Meeting

What Happened
Anavex Life Sciences Corp. announced on August 3, 2026 (via an 8-K, Item 7.01) that it plans to refresh its Board of Directors at its 2026 Annual Meeting of Stockholders. The company issued a press release that includes an open letter to stockholders responding to a preliminary proxy statement filed by PVG Asset Management Corporation and Patrick S. Adams, who seek to replace the entire Anavex Board. The press release was furnished as Exhibit 99.1 to the Current Report.

Key Details

• Press release and open letter dated August 3, 2026 were furnished under Item 7.01 (Regulation FD Disclosure) and are included as Exhibit 99.1.
• Dissident parties named: PVG Asset Management Corporation and Patrick S. Adams; their preliminary proxy statement requests replacement of the entire Board.
• The Board refresh is to occur at Anavex’s 2026 Annual Meeting of Stockholders; the 8-K documents the company’s public response to the proxy challenge.

Why It Matters
This filing signals an active proxy contest over board control, which is a governance event investors should monitor. A contested election could result in changes to Anavex’s board composition and oversight, potentially affecting company strategy and leadership. The 8-K is a formal disclosure of the company’s position and the related press materials shareholders will use to evaluate the upcoming vote.